Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2008
11/19/2008EP1991276A2 Treatment of tendinopathy by inhibition of molecules that contribute to cartilage formation
11/19/2008EP1991275A2 Complement binding aptamers and anti-c5 agents useful in the treatment of ocular disorders
11/19/2008EP1991274A1 Method of treatment, prophylaxis and diagnosis of pathologies of the bone
11/19/2008EP1513553B1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
11/19/2008EP1472288B1 Viral cd30 polypeptide
11/19/2008EP1417349B1 Novel molecular target for neurotoxicity
11/19/2008EP1300158B9 Pharmaceutical compositions for angiogenic therapy
11/19/2008EP1268775B1 The high bone mass gene of 11q13.3
11/19/2008EP1108780B1 Nucleic acid sequence for potentiating the expression of useful gene and method therefor
11/19/2008EP0745122B1 Galanin receptor, nucleic acids, transformed cells and uses thereof
11/19/2008CN101310010A Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same
11/19/2008CN101307330A BA46 recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307329A Her-2/neu recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307328A CK19 recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307327A CEA recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307326A PSA recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307325A PSMA recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307085A SiRNA and recombination lentivirus from preventing hepcidin from regulating protein and uses thereof
11/19/2008CN100434521C Structure and application of antisense oligonucleotide with gene of mid-range factor as target
11/19/2008CN100434519C Curing and preventing method
11/18/2008US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα
11/18/2008US7452964 Compositions and methods of use of targeting peptides against placenta and adipose tissues
11/18/2008US7452916 Administering arginine, lysine; cardiovascular disorder therapy
11/18/2008US7452869 For modulating necrosis and treating neurological/ cardiovascular diseases
11/18/2008US7452859 Having serine protease inhibitory activity
11/18/2008US7452717 Carboxylesterase; antitumor agents; drug screening; bioassay
11/18/2008US7452716 Plasmid for use as gene transfer vechicle in the treatment of genetic disorders
11/18/2008US7452536 Inhibiting OX-2 (also called CD200) gene expression to treat a tumor that is associated with increased CD200 expression; leukemia; phage display screening for antigens; monoclonal antibodies; fusion proteins; use of OX-2 preventing graft rejection, autoimmune disease, and in inducing tumor cell growth
11/18/2008US7452531 Compositions and methods for tumor-targeted delivery of effector molecules
11/18/2008US7452529 Treatment of muscular dystrophy with cord blood cells
11/18/2008CA2632032A1 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly
11/18/2008CA2589613A1 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly
11/18/2008CA2501743C Gas driven gene delivery instrument
11/18/2008CA2381219C Monomeric protein of the tgf-beta family
11/18/2008CA2265444C Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
11/18/2008CA1341585C Recombinant retroviruses
11/14/2008CA2685257A1 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
11/13/2008WO2008137867A2 Compositions comprising mir34 therapeutic agents for treating cancer
11/13/2008WO2008137758A2 Amino acid lipids and uses thereof
11/13/2008WO2008137490A2 Systemic insulin-like growth factor-1 therapy reduces diabetic peripheral neuropathy and improves renal function in diabetic nephropathy
11/13/2008WO2008137114A1 Methods and compositions for targeted delivery of gene therapeutic vectors
11/13/2008WO2008136902A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/13/2008WO2008136852A2 Methods and compositions related to the structure and function of apobec3g
11/13/2008WO2008136438A1 Viral vector for gene therapy
11/13/2008WO2008136213A1 Radiosensitivity-enhancing agent
11/13/2008WO2008135562A1 Self-precipitating pharmaceutical formulations for the modified release of active principle
11/13/2008WO2008134879A1 Il-12 immunotherapy for cancer
11/13/2008WO2008134878A1 Compositions and methods for cancer treatment
11/13/2008WO2008109837A3 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
11/13/2008WO2008094516A3 Multi-targeting short interfering rnas
11/13/2008WO2008090416A3 Tumor suppressor functions of the rb-skp2 pathway are disabled in high risk but functional in low-risk neuroblastomas
11/13/2008WO2008082438A3 Chd5 is a novel tumor suppressor gene
11/13/2008WO2008021160B1 Regulation of litaf modulated cytokine production by a novel p53 short peptide
11/13/2008WO2008019346A3 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
11/13/2008WO2007122369A8 Novel tumour suppressor
11/13/2008WO2007109131A3 Lentiviral vectors that provide improved expression and reduced variegation after transgenesis
11/13/2008WO2007100808A3 Method and process for preparing cardiolipin
11/13/2008US20080280823 Treatment of Non-Alcoholic Steatotic Hepatitis (Nash)
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080280811 Carbonic Anhydrase-1 and 2 signal inhibitor; of Vascular Endothelial Growth Factor signal inhibitor; kallikrein, kinin pathway inhibitor; Complement-1 Inhibitor agonist; injection into vitreous or aqueous humor of the eye; candidates by tested for significant difference in level of protein, mRNA
11/13/2008US20080280354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
11/13/2008US20080279950 Nano-particles comprising cucurbituril derivatives, pharmaceutical composition containing the same, and process for the preparation thereof
11/13/2008US20080279945 Water soluble gel; gene expression of nucleic acid segments encoding therapy constructs including peptides, polypeptides, ribozymes and catalytic Rna to cells or tissues of animals; cardiovascular disorders; muscular dystrophy
11/13/2008US20080279887 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug.
11/13/2008US20080279872 Using dendritic cells expressing chymotrypsin protein fragment as immunostimulatory tool for targeting cancer cells associated with ovarian tissue
11/13/2008US20080279871 Immunogenic composition
11/13/2008US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells
11/13/2008US20080279849 B lymphocyte chemoattractant (CXCL13) specific immunoglobulin for use in treatment and prevention of autoimmune encephalomyelitis
11/13/2008US20080279846 lipoprotein-associated phospholipase A2 (Lp-PLA2)
11/13/2008US20080279764 Method and composition for treating cancer
11/13/2008CA2723320A1 Il-12 immunotherapy for cancer
11/13/2008CA2686735A1 Amino acid lipids and uses thereof
11/13/2008CA2685873A1 Self-precipitating pharmaceutical formulations for the modified release of active principle
11/13/2008CA2685840A1 Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis
11/13/2008CA2685453A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/13/2008CA2685417A1 Viral vector for gene therapy
11/12/2008EP1990415A1 Osteoprotegerin
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990040A1 Nanoparticle delivery vehicle
11/12/2008EP1989316A2 Method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions
11/12/2008EP1989308A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases
11/12/2008EP1989299A2 Meganuclease variants cleaving a dna target sequence from a xeroderma pigmentosum gene and uses thereof
11/12/2008EP1988926A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/12/2008EP1809336B1 Growth hormone releasing hormone enhances the immune response induced by vaccination
11/12/2008EP1465912B1 Chimeric tnf ligands
11/12/2008EP1432729B1 Peyers's patch and/or m-cell targeting ligands
11/12/2008EP1424894B1 Inhibition of pathological angiogenesis in vivo
11/12/2008EP1206525B1 Method for growing stem cells
11/12/2008EP1147179B1 Human liver progenitors
11/12/2008EP0950103B1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
11/12/2008EP0850313B1 Improved aav vectors for gene therapy
11/12/2008EP0792359B1 Transcription factor e2f-4
11/12/2008EP0750668B1 Novel muteins of ifn-beta
11/12/2008CN101305091A Isolated myeloid-like bone marrow cell populations and methods of treatment therewith
11/12/2008CN101304766A Erythrosin-based antimicrobial photodynamic therapy compound and its use
11/12/2008CN101302536A Virus envelope vector for gene transfer
11/12/2008CN101302524A Fusion gene of Toxoplasma gondii multi-epitope gene and cholera toxin CTXA2/B subunit and use thereof
11/12/2008CN101301478A G-tetrad oligonucleotide using hypoxia inducible factor 1-alpha (HIFI alpha) as target
11/12/2008CN100432229C Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
11/12/2008CN100432105C Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with 1L-2
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 870